A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic and regimens as first-line therapy for advanced colorectal cancer
Kamel Bouzid, S. Khalfallah, J. Tujakowski, B. Piko, G. Purkalne, S. Plate, P. Padrik, M. Serafy, E. M. Pshevloutsky, B. Boussard, P. P. Bapsy, S. Ben Ahmed, T. Salek, S. Doneo, D. A. Gerges, D. C. Doval, E. Buyukunal, I. N. Chernozemsky, V. I. Tzekova, H. A. El-AzimH. Errihani, R. Samlali, J. S. Godz, N. Ghilezan, B. A. Berdov, G. N. Tchaikovsky, M. Wagnerova, N. F. Aykan, J. Zidan, G. Chachine
Research output: Contribution to journal › Article › peer-review
22Scopus
citations
Fingerprint
Dive into the research topics of 'A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic and regimens as first-line therapy for advanced colorectal cancer'. Together they form a unique fingerprint.